Literature DB >> 22515293

FoxP3 mRNA splice forms in synovial CD4+ T cells in rheumatoid arthritis and psoriatic arthritis.

L Rebekka Ryder1, Else Marie Bartels, Anders Woetmann, Hans Ole Madsen, Niels Odum, Henning Bliddal, Bente Danneskiold-Samsøe, Søren Ribel-Madsen, Lars P Ryder.   

Abstract

Our aim was to elucidate the relative amount of the different splice forms of FoxP3 mRNA in CD4+ T cells in peripheral blood (PB) compared to synovial fluid (SF) in RA and PsA patients. FoxP3 mRNA was measured using a quantitative real-time PCR method. CD4+ T cells were isolated from 17 paired samples of PB and SF from RA and PsA patients, and PB from 10 controls. FoxP3fl and FoxP3Δ2 mRNA was significantly increased (6.7 and 2.1-fold, respectively) in PB CD4+ T cells from RA patients compared to controls. FoxP3fl and Δ2 mRNA in SF CD4+ T cells was increased compared to controls in sero-negative RA and PsA, but not in sero-positive RA patients, who had a high FoxP3 expression in both PB and SF. The FoxP3Δ2Δ7 mRNA was barely detectable in patient samples, and not at all in healthy individuals. We provide evidence of an increased expression of FoxP3 splice forms in synovial CD4+ T cells from RA patients. A skewed, high expression profile of FoxP3, but not CTLA-4, in sero-negative RA and PsA, indicates that synovial CD4+ T cells may represent unique subsets of T cells which have been induced locally or selectively recruited to the joint.
© 2011 The Authors. APMIS © 2011 APMIS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22515293     DOI: 10.1111/j.1600-0463.2011.02848.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  12 in total

1.  Transcriptional network profile on synovial fluid T cells in psoriatic arthritis.

Authors:  Ugo Fiocco; Veronica Martini; Benedetta Accordi; Francesco Caso; Luisa Costa; Francesca Oliviero; Anna Scanu; Monica Facco; Daniele Boso; Mariele Gatto; Mara Felicetti; Paola Frallonardo; Roberta Ramonda; Lucia Piva; Renato Zambello; Carlo Agostini; Raffaele Scarpa; Giuseppe Basso; Gianpietro Semenzato; Jean-Michel Dayer; Leonardo Punzi; Andrea Doria
Journal:  Clin Rheumatol       Date:  2015-07-09       Impact factor: 2.980

Review 2.  The regulation of immune tolerance by FOXP3.

Authors:  Ling Lu; Joseph Barbi; Fan Pan
Journal:  Nat Rev Immunol       Date:  2017-07-31       Impact factor: 53.106

3.  Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto's thyroiditis.

Authors:  B Kristensen; L Hegedüs; H O Madsen; T J Smith; C H Nielsen
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

4.  FOXP3 exon 2 controls Treg stability and autoimmunity.

Authors:  Jianguang Du; Qun Wang; Shuangshuang Yang; Si Chen; Yongyao Fu; Sabine Spath; Phillip Domeier; David Hagin; Stephanie Anover-Sombke; Maya Haouili; Sheng Liu; Jun Wan; Lei Han; Juli Liu; Lei Yang; Neel Sangani; Yujing Li; Xiongbin Lu; Sarath Chandra Janga; Mark H Kaplan; Troy R Torgerson; Steven F Ziegler; Baohua Zhou
Journal:  Sci Immunol       Date:  2022-06-24

Review 5.  The Potential Role of Inhibitory Receptors in the Treatment of Psoriasis.

Authors:  Neha Shah; Sabina Sandigursky; Adam Mor
Journal:  Bull Hosp Jt Dis (2013)       Date:  2017-05

Review 6.  Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity.

Authors:  Sofie Bliddal; Claus Henrik Nielsen; Ulla Feldt-Rasmussen
Journal:  F1000Res       Date:  2017-09-28

Review 7.  Alternative Splicing of FOXP3-Virtue and Vice.

Authors:  Reiner K W Mailer
Journal:  Front Immunol       Date:  2018-03-13       Impact factor: 7.561

8.  Increased miR-142-3p Expression Might Explain Reduced Regulatory T Cell Function in Granulomatosis With Polyangiitis.

Authors:  Gerjan J Dekkema; Theo Bijma; Pytrick G Jellema; Anke Van Den Berg; Bart-Jan Kroesen; Coen A Stegeman; Peter Heeringa; Wayel H Abdulahad; Jan-Stephan Sanders
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

9.  Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.

Authors:  Alejandro Ibáñez-Costa; Carlos Perez-Sanchez; Alejandra María Patiño-Trives; Maria Luque-Tevar; Pilar Font; Ivan Arias de la Rosa; Cristobal Roman-Rodriguez; Mª Carmen Abalos-Aguilera; Carmen Conde; Antonio Gonzalez; Sergio Pedraza-Arevalo; Mercedes Del Rio-Moreno; Ricardo Blazquez-Encinas; Pedro Segui; Jerusalem Calvo; Rafaela Ortega Castro; Alejandro Escudero-Contreras; Nuria Barbarroja; Mª Angeles Aguirre; Justo P Castaño; Raul M Luque; Eduardo Collantes-Estevez; Chary Lopez-Pedrera
Journal:  Ann Rheum Dis       Date:  2021-10-08       Impact factor: 19.103

10.  Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis.

Authors:  Agnes Szentpetery; Eric Heffernan; Martina Gogarty; Lisa Mellerick; Janet McCormack; Muhammad Haroon; Musaab Elmamoun; Phil Gallagher; Genevieve Kelly; Aurelie Fabre; Brian Kirby; Oliver FitzGerald
Journal:  Arthritis Res Ther       Date:  2017-07-05       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.